Michael Gold

Professor Michael Gold is a Paediatric Allergist and Immunologist in the Discipline of Paediatrics, University of Adelaide and the Department of Allergy and Immunology at the Women’s and Children’s Health Network, Adelaide, Australia. He trained in paediatrics at the Red Cross Childrens Hospital, Cape Town and was awarded a post-graduate Medical Doctorate from the University of Cape Town (UCT). He has had a research and clinical interest in vaccine safety for many decades. He was appointed to the World Health Organisation Global Advisory Committee for Vaccine Safety in 2010 and has been an advisor to the Australian Therapeutic Goods Administration via his appointment to a number of expert advisory groups since 2006. He has been awarded a number of Australian national research grants for projects that have researched novel methods of vaccine safety surveillance including data linkage and m-Health. He has contributed to a number of key WHO guidelines and training materials which include; the WHO vaccine reaction sheets, the Adverse Event Following Immunisation surveillance manual, the WHO guideline on causality assessment, the guideline for Immunisation stress related responses and the global manual for COVID vaccine safety surveillance. He has participated in numerous WHO organised training courses to strengthen adverse event surveillance and causality assessment systems in Low and Middle Income Countries. From 2020-2022, he was appointed as a consultant to the WHO South East Asian Region, to facilitating the implementation of COVID vaccine pharmacovigilance. Since 2007, he has contributed to the UCT Vaccines for Africa initiative, through research collaborations and presentations at the annual vaccinology course and during the pandemic he was appointed to the WHO African Advisory Committee for Vaccine Safety (sub-committee).